Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
00460 SIHUAN PHARM
1.110
-0.010-0.89%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30
Turnover
33.56% 3.29B 80.86% 1.91B -14.39% 2.46B -36.38% 1.05B
Operating income
33.56% 3.29B 80.86% 1.91B -14.39% 2.46B -36.38% 1.05B
Cost of sales
-53.29% -842.75M -63.92% -440.1M 6.66% -549.78M 8.08% -268.48M
Operating expenses
-53.29% -842.75M -63.92% -440.1M 6.66% -549.78M 8.08% -268.48M
Gross profit
27.9% 2.45B 86.64% 1.47B -16.38% 1.91B -42.44% 786.06M
Selling expenses
-48.45% -547.49M -91.13% -260.92M -50.29% -368.79M -15.76% -136.52M
Administrative expenses
-24.03% -607.49M -31.35% -278.66M -3.86% -489.78M 4.57% -212.16M
Research and development expenses
-19.05% -868.07M -10.87% -333.57M -21.74% -729.16M -28.76% -300.85M
Impairment and provision
-- -131.3M -- -- -- -- -- --
-Impairment of intangible assets
-- -131.3M -- -- -- -- -- --
Special items of operating profit
2.03% 469.77M 63.49% 291.99M -22.21% 460.41M -49.95% 178.6M
Operating profit
-2.95% 763.94M 181.14% 885.96M 132.71% 787.13M 118.59% 315.14M
Financing cost
-1352% -119.31M -894.83% -15.78M -74.31% -8.22M 32.85% -1.59M
Special items of earning before tax
-1113.88% -158.58M -343.6% -50.7M -8.72% -13.06M -60.23% -11.43M
Earning before tax
-36.53% 486.05M 171.24% 819.48M 131.61% 765.84M 117.72% 302.12M
Tax
-15.63% -253.28M -68.83% -225.27M 24.57% -219.04M 43.75% -133.43M
After-tax profit from continuing operations
-57.43% 232.77M 252.25% 594.22M 120.15% 546.8M 108.69% 168.69M
After-tax profit from non-continuing business
-- -- -- -- 20.59% -34.92M -11.19% -24.44M
Earning after tax
-54.53% 232.77M 311.92% 594.22M 118.56% 511.89M 107.34% 144.26M
Minority profit
-577.18% -183.74M -200.12% -17.21M 1067.71% 38.51M -110.26% -5.73M
Profit attributable to shareholders
-12.01% 416.51M 307.64% 611.42M 117.19% 473.38M 107.43% 149.99M
Basic earnings per share
-11.6% 0.0442 308.86% 0.0646 117.18% 0.05 107.41% 0.0158
Diluted earnings per share
-12.2% 0.0439 306.33% 0.0642 117.18% 0.05 107.41% 0.0158
Currency Unit
CNYCNYCNYCNY
Accounting Standards
IASIASIASIAS
Audit Opinions
Unqualified Opinion--Unqualified Opinion--
Auditor
Ernst & Young accounting firm--Ernst & Young accounting firm--

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Sihuan Pharmaceutical holding Group Co., Ltd. is a Hong Kong investment holding company engaged in pharmaceutical business. The company is mainly engaged in drug research and development, manufacturing and sales in China. Its products cover cardio-cerebrovascular, central nervous system, metabolism, tumor and anti-infection fields. Its products include cardiovascular and cerebrovascular products such as Klingo, Agili and Odime, as well as non-cardiovascular and cerebrovascular products such as Renao, metronidazole and roxatidine.
CEO: Fengsheng Che
Market: Hong Kong motherboard
Futu Hot List
HKUSCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top